Alemtuzumab as Second-Line Treatment for Late Antibody-Mediated Rejection of Transplanted Kidneys
- Michiel G.H. Betjes*
- , Marcia M.L. Kho
- , Nicolle H.R. Litjens
- , Annelies E. de Weerd
- , Joke I. Roodnat
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
9
Citations
(Scopus)
180
Downloads
(Pure)